Defense Advanced Research Projects Agency Grants $23 Million Contract to Battelle, NxStage Medical, Inc. and Aethlon Medical for a Sepsis Treatment

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Battelle, NxStage and Aethlon will collaborate on a mobile medical device to treat sepsis in soldiers, funded by a $23M contract with DARPA. The U.S. Defense Advanced Research Projects Agency (DARPA) handed a $23 million contract to 3 companies, Battelle, NxStage (NSDQ:NXTM) and Aethlon (OTC:AEMD), who will collaborate on a sepsis treatment device for the military. The project, which DARPA is calling the Dialysis-Like Therapeutics (DLT) program, will be funded in phases and the companies are tasked with building a portable sepsis treatment device.

Help employers find you! Check out all the jobs and post your resume.

Back to news